1. p53-Mediated Radiosensitization of 177Lu-DOTATATE in Neuroblastoma Tumor Spheroids
   Sara Lundsten et al, 2021, Biomolecules CrossRef
2. The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach
   Diana Spiegelberg et al, 2020, Scientific Reports CrossRef
3. Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research
   Alina Doctor et al, 2020, Cancers CrossRef
4. In Vitro Characterization of 177Lu-DOTA-M5A Anti-Carcinoembryonic Antigen Humanized Antibody and HSP90 Inhibition for Potentiated Radioimmunotherapy of Colorectal Cancer
   Tabassom Mohajershojai et al, 2022, Frontiers in Oncology CrossRef
5. Promising targetable biomarkers in pancreatic neuroendocrine tumours
   M. Borghesani et al, 2023, Expert Review of Endocrinology & Metabolism CrossRef
6. p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
   Hanna Berglund et al, 2024, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
7. EANM position paper on the role of radiobiology in nuclear medicine
   An Aerts et al, 2021, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
8. Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward
   Danny Feijtel et al, 2020, Current Topics in Medicinal Chemistry CrossRef
9. Neuroendocrine Lung Cancer Mouse Models: An Overview
   Corina Lorz et al, 2020, Cancers CrossRef